Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Clinical trial NCT01402531 · COMPLETED
Trial details
- NCT number
- NCT01402531
- Sponsor
- University of California, San Diego
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-22
- Primary completion
- 2013-07-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.